ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

The Potential of Immunotherapy in TNBC

Elizabeth A. Mittendorf, MD, PhD
Published Online:1:50 PM, Wed May 3, 2017

Elizabeth A. Mittendorf, MD, PhD, associate professor, department of surgical oncology, University of Texas MD Anderson Cancer Center, discusses the promise immunotherapy has shown thus far in breast cancer, particularly triple-negative breast cancer (TNBC). 
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.